COMMON STOCK PURCHASE WARRANT Issue Date: December 16, 2015 To Purchase 50,000 Shares of Common Stock of VIVEVE MEDICAL, INC.Atkinson James G. • December 21st, 2015 • Electromedical & electrotherapeutic apparatus
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, Jim Atkinson (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) and on or prior to the close of business on the earlier of the tenth anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Viveve Medical, Inc., a Yukon Territory corporation (the “Company”), up to an aggregate of 50,000 shares (the “Warrant Shares”) of the Company’s common stock, no par value (the “Common Stock”) in accordance with Section 3 or Section 4 herein. The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $0.70 subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.
Agreement of Joint FilingAgreement of Joint Filing • December 3rd, 2015 • Atkinson James G. • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Viveve Medical, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
Agreement of Joint FilingAgreement of Joint Filing • December 21st, 2015 • Atkinson James G. • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Viveve Medical, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
Agreement of Joint FilingAgreement of Joint Filing • June 23rd, 2016 • Atkinson James G. • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Viveve Medical, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
Agreement of Joint FilingAgreement of Joint Filing • May 22nd, 2015 • Atkinson James G. • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Viveve Medical, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
LOCK-UP AGREEMENTLock-Up Agreement • June 23rd, 2016 • Atkinson James G. • Electromedical & electrotherapeutic apparatus • New York
Re: Underwriting Agreement, dated June 14, 2016, by and between Viveve Medical, Inc. and Ladenburg Thalmann & Co. Inc., acting as representative to the several underwriters
COMMON STOCK PURCHASE WARRANT Issue Date: May 12, 2015 To Purchase 217,733 Shares of Common Stock of VIVEVE MEDICAL, INC.Atkinson James G. • December 3rd, 2015 • Electromedical & electrotherapeutic apparatus
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, James Atkinson (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) and on or prior to the close of business on the earlier of the tenth anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Viveve Medical, Inc., a Yukon Territory corporation (the “Company”), up to an aggregate of 217,733 shares (the “Warrant Shares”) of the Company’s common stock, no par value (the “Common Stock”) in accordance with Section 3 or Section 4 herein. The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $0.53, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.
